Zdrowie i gospodarka · 04/08/2015

Evidentiary Considerations for Integration of Biomarkers in Drug Development: Public Meeting and Request for Comments

The FDA, in collaboration with the University of Maryland's Center of Excellence in Regulatory Science and Innovation and the Critical Path Institute, is hosting a public workshop to discuss current scientific approaches to biomarker development and their role in drug development programs.